A Critical Mission

In July, our CEO, Andrew Witty, traveled to some of the poorest towns in Kenya to observe three GSK programs: Positive Action, PHASE (Personal Hygiene And Sanitation Education), and the Kambawa site for our malaria vaccine clinical trial.

The GSK-supported Zingatia Maisha project of Positive Action is geared toward improving HIV/AIDs patient care through increased access to anti-retroviral treatments and enhanced patient care and clinical practice.  GSK developed PHASE as a straightforward educational campaign to increase awareness of critical personal hygiene and sanitation issues, and improve simple practices such as rigorous hand-washing that can make a huge difference in limiting disease.

As with so many educational and access programs we support, GSK works closely on these initiatives with an important partner: AMREF, the leading health development organization in Africa.

Read more about Andrew's trip in the Guardian.

Check out the video of Andrew in Africa.

(Photo courtesy of the Guardian.)